Flick International High-tech Tesla car parked beneath the New York Times building, symbolizing conflict over drug use report

Elon Musk Faces Accusations from New York Times Over Drug Use Reports

Elon Musk Faces Allegations of Intense Drug Use Reported by New York Times

The New York Times has accused Tesla CEO Elon Musk of engaging in harmful behavior directed towards them following the publication of a controversial report on his alleged drug use.

In May, the New York Times unveiled a report which relied on private messages and interviews with more than a dozen individuals familiar with Musk’s life. The report suggests that Musk’s drug use may have been significantly more intense than previously acknowledged, particularly as he campaigned with former President Donald Trump for the 2024 election.

According to the New York Times, Musk reportedly told acquaintances about his significant ketamine use, claiming it had detrimental effects on his bladder, a known consequence of chronic use. The article also mentions that Musk used Ecstasy and psychedelic mushrooms. Furthermore, he was seen with a daily medication box allegedly containing around 20 pills, which included stimulant Adderall.

Musk’s Response to the Allegations

In a bid to refute the claims made by the New York Times, Musk shared the results of a recent drug test on his account on X, the platform previously known as Twitter.

The communications team at the New York Times responded promptly, reiterating their support for the story and asserting that Musk was simply reacting negatively because he disliked their coverage. They stated that none of Musk’s comments or evidence presented contradicted their findings.

The New York Times Communications account made it clear that they stand by their reporting, stating, “Elon Musk is continuing to lash out because he doesn’t like our reporting.” They emphasized their confidence in the authenticity of the information gathered during their investigation.

A Challenge Issued by Musk

In the wake of the controversy, Musk challenged both the New York Times and the Wall Street Journal to take drug tests and publish their results. He mockingly declared, “Great idea. I hereby challenge the NYT and WSJ to take drug tests and publish the results! They won’t, because those hypocrites are guilty as sin.” This statement indicates Musk’s ongoing contention with the media outlets covering his personal life.

The Back-and-Forth Continues

The tension between Musk and the New York Times has persisted since the article’s publication on May 30. Just a day after the initial report went live, Musk used X to profess that the New York Times was “lying their a– off,” vehemently denying any use of ketamine for years.

In response, the New York Times Communications team reiterated their commitment to the truth. They accused Musk of trying to deflect attention from the serious claims made against him without providing any corroborative evidence.

The Credibility of the Report

The New York Times report, penned by journalists Kirsten Grind and Megan Twohey, was built on solid foundations, featuring in-depth interviews and various forms of evidence. They consulted with numerous individuals who have interacted with Musk personally and professionally, while also reviewing private texts, legal documents, and photographs that support their claims regarding his drug use and familial issues.

In the eyes of the New York Times Communications team, Musk’s public denials and confrontations are simply attempts to divert attention from the substance of the piece. They maintained that they offered Musk multiple chances to provide a response or counter-argument prior to the article’s release. However, Musk chose to opt for social media distractions instead of engaging directly with their findings.

The Implications of Musk’s Alleged Drug Habits

The revelations regarding Musk’s alleged drug use raise broader questions about the impact of substance abuse on high-profile individuals, particularly those in positions of power. As the CEO of Tesla, a company influential in the automotive and technology sectors, any implications of drug misuse could have significant repercussions not only for Musk personally but also for the companies he represents.

Moreover, this incident highlights the role of journalism in shedding light on potential issues often obscured by fame and power. The New York Times aims to hold influential figures accountable, illustrating how they balance the pursuit of truth with the responsibility of reporting on sensitive subjects.

A Look Ahead

As the story unfolds, it remains to be seen how Musk will navigate this ongoing conflict with the media and whether any new developments will emerge. His public profile continues to grow, and the pressure surrounding him may intensify as scrutiny increases.

Both Musk and the New York Times find themselves at a crossroads, with each party standing firm in its position. Musk’s challenges to the New York Times and the Wall Street Journal to divulge their own drug-test results could either escalate tensions or lead to a new phase in the ongoing feud.